Itonic Holdings Ltd income statement
In fiscal 2025, Itonic Holdings Ltd reported revenue of $523,031, up 16.7% on the year before, operating income of −$5.2m (a -991.7% margin) and net income of −$5.1m, or −$0.32 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 |
|---|---|---|---|---|
| Revenue | 680 | 629 | 448 | 523 |
| Cost of revenue | 122 | 158 | 67 | 196 |
| Gross profit | 558 | 471 | 381 | 327 |
| Research and development | 74 | 84 | 93 | 459 |
| Selling and marketing | 295 | 268 | 308 | 182 |
| General and administrative | 162 | 425 | 751 | 4,873 |
| Operating income | 28 | −307 | −770 | −5,187 |
| Income before tax | 71 | −261 | −639 | −5,098 |
| Income tax | −13 | −19 | 22 | — |
| Net income | 84 | −241 | −661 | −5,098 |
| Diluted EPS | $0.01 | −$0.02 | −$0.05 | −$0.32 |
| Diluted shares (average) | 12m | 12m | 13m | 16m |
Compare with peers
- Co-diagnostics, Inc. income statement
- Qtrex Quantum Ltd. income statement
- Pulse Biosciences, Inc. income statement
- Nexalin Technology, Inc. income statement
- Insight Molecular Diagnostics Inc. income statement
Head to head: CODX vs ITOCITOC vs QTEXITOC vs PLSE
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies